TARS - Tarsus Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TARS is currently covered by 5 analysts with an average price target of $92.01. This is a potential upside of $22.26 (31.91%) from yesterday's end of day stock price of $69.75.

Tarsus Pharmaceuticals 's activity chart (see below) currently has 49 price targets and 41 ratings on display. The stock rating distribution of TARS is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.08% with an average time for these price targets to be met of 398.63 days.

Highest price target for TARS is $84, Lowest price target is $51, average price target is $68.6.

Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 02-Jun-2025. First documented stock forecast 10-Nov-2020.

Currently out of the existing stock ratings of TARS, 10 are a BUY (83.33%), 2 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$75

$9.83 (15.08%)

$72

4 months 6 days ago
(02-Jun-2025)

6/9 (66.67%)

$31.15 (71.04%)

516

Hold

$51

$-14.17 (-21.74%)

$41

5 months 3 days ago
(05-May-2025)

4/4 (100%)

$3 (6.25%)

87

Buy

$84

$18.83 (28.89%)

$78

5 months 6 days ago
(02-May-2025)

3/5 (60%)

$36.64 (77.36%)

457

Buy

$73

$7.83 (12.01%)

$61

7 months 12 days ago
(26-Feb-2025)

9/10 (90%)

$30.44 (71.52%)

601

Buy

$60

$-5.17 (-7.93%)

$62

7 months 12 days ago
(26-Feb-2025)

5/5 (100%)

$17.44 (40.98%)

415

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TARS (Tarsus Pharmaceuticals ) average time for price targets to be met?

On average it took 398.63 days on average for the stock forecasts to be realized with a an average price target met ratio 77.08

Which analyst has the current highest performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

EDDIE HICKMAN

Which analyst has the current lower performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

DANE LEONE

Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals )?

Eddie Hickman works at GUGGENHEIM and has 9 price targets and 7 ratings on TARS

Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals )?

Dane Leone with highest potential upside - $51.89

Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals )?

Anthony Petrone with lowest potential downside - -$21.17

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?